Anti-Nicotinic Acetylcholine Receptor alpha 5 抗体 (ab41173)

製品の概要

  • 製品名Anti-Nicotinic Acetylcholine Receptor alpha 5 antibody
    Nicotinic Acetylcholine Receptor alpha 5 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to Nicotinic Acetylcholine Receptor alpha 5
  • 特異性Antiserum Specificity Polypeptide % Cross Reactivity Nicotinic a5 receptor (460-468) 100%, Nicotinic a5 receptor ~95%, Nicotinic a3 receptor 0%, Nicotinic a4 receptor 0%, Nicotinic a7 receptor 0%, Nicotinic ß2 receptor 0%, Nicotinic ß3 receptor 0%, Nicotinic ß4 receptor 0%.
  • アプリケーション適用あり: ICC/IF, ELISA, WBmore details
  • 種交差性
    交差種: Human, Chimpanzee, Monkey
  • 免疫原

    Synthetic peptide:

    PVHIGNANK

    , corresponding to C terminal amino acids 460-468 of Nicotinic Acetylcholine Receptor alpha 5

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab41173 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ICC/IF
ELISA
WB
  • 追加情報ELISA: Use at an assay dependent dilution.
    ICC/IF: 1/400.
    WB: 1/1600. Predicted molecular weight: 53 kDa.

    With this antibody, we have found that blocking with 5% goat or donkey serum significantly reduces background as compared to BSA or milk.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • ターゲット情報

    • 機能After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
    • 配列類似性Belongs to the ligand-gated ion channel (TC 1.A.9) family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-5/CHRNA5 sub-subfamily.
    • 細胞内局在Cell junction > synapse > postsynaptic cell membrane. Cell membrane.
    • Information by UniProt
    • 参照データベース
    • 別名
      • Acetylcholine receptor nicotinic alpha 5 (neuronal) antibody
      • ACHA5_HUMAN antibody
      • AChR antibody
      • Cholinergic receptor neuronal nicotinic alpha polypeptide 5 antibody
      • Cholinergic receptor nicotinic alpha 5 antibody
      • Cholinergic receptor nicotinic alpha polypeptide 5 antibody
      • CHRNA 5 antibody
      • CHRNA5 antibody
      • LNCR2 antibody
      • NACHRA 5 antibody
      • NACHRA5 antibody
      • Neuronal acetylcholine receptor subunit alpha 5 antibody
      • Neuronal acetylcholine receptor subunit alpha-5 antibody
      • Neuronal nicotinic acetylcholine receptor alpha 5 subunit antibody
      • Neuronal nicotinic acetylcholine receptor, alpha5 subunit antibody
      • OTTHUMP00000185019 antibody
      see all

    Anti-Nicotinic Acetylcholine Receptor alpha 5 antibody (ab41173) 使用論文

    This product has been referenced in:
    • Calleja-Macias IE  et al. Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int J Cancer 124:1090-6 (2009). WB ; Human . Read more (PubMed: 19048619) »

    See 1 Publication for this product

    Product Wall

    Thank you for your message and for providing this further information. I appreciate the time your customer has spent on these experiments and would be pleased to arrange a replacement or a credit note in compensation. I look forward to hearing from...

    Read More

    Thank you for your cooperation. As requested, I have asked our accounting department to issue you with a credit note. This can then be redeemed against the invoice of a future order. As usual if you have any further questions regarding this credi...

    Read More

    Thank you for taking time to complete our questionnaire. I am sorry to hear that this antibody is not providing satisfactory results. The details provided will enable us to investigate this case and will provide us with vital information for monitor...

    Read More

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"